Drug Discovery Market – Size, Outlook, Trends, and Forecast (2024 – 2032)

Published : 30 Aug 2024

Report Type : Global

Share This On

Download Free Sample Now Buy This Report

Home > Reports > Pharmaceuticals > Healthcare > Drug Discovery Market – Size, Outlook, Trends, and Forecast (2024 – 2032)

Description Table of Contents Scope of the Report

Drug Discovery Market - Size

Study Period

2018 - 2030

Base Year For Estimation

2023

Forecast Data Period

2024-2030

Historical Data Period

2018-2021

CAGR

7 %

Source: Envision Intelligence Analysis & Experts Insights.

*Graph shown for illustrative purpose only, the final report will have the graph with actual data and data labels

The global drug discovery market is projected to grow from $33998 million in 2018 to $68684 million by 2024 growing at a CAGR of 9.20% during the forecast period. Drug discovery is a process of inventing a new medication in the field of pharmaceuticals, biotechnology and pharmacology. It is a complicated, lengthy and expensive process. Though advanced technologies are available, the success rate of drug discovery is meagre and the time involved is relatively high.

Global Drugs Discovery Market Share:

Compared to the past years, Global Drugs Market has undergone a predominant change in the markets. Pharmaceutical Services is expected to have the highest growth rate when compared with other segments.

Global Drugs Discovery Market Size:

Geographically, the global drug discovery outsourcing market can be categorised into North America, Europe, Asia-Pacific and rest of the world regions. North America currently holds the most significant share in this market and is followed by Europe due to the existence and early adoption of highly developed technologies and supportive economy. Asia-Pacific is a promising market for drug discovery outsourcing and is expected to undergo rapid market growth.

Global Drugs Discovery Market Growth:

High prevalence of health

Drug Discovery Market - Growth

Source: Envision Intelligence Analysis & Experts Insights.

*Graph shown for illustrative purpose only, the final report will have the graph with actual data and data labels

disorders such as genetic disorders, nervous system disorders, diabetes, cardiovascular diseases and others; rising demand for novel drug discovery technologies owing to the growing population; and advancements in the field of biotechnology, molecular biology and genomics. Moreover, the populated pipeline for novel drugs coupled with the patent expiry of several other drugs and increased expenditure on healthcare is also driving the market growth.

Global Drugs Discovery Market Industry Analysis:

The drug discovery market by the technology is segmented into QPCR, DNA microarrays, protein microarrays, high-throughput screening, mass spectrometry, etc. By service, The market is segmented into Pharmaceutical Services, Drug Metabolism and Pharmacokinetics (DMPK) Services, etc. By End-users, The market is segmented into Biotech companies, Pharmaceutical companies, etc.

Global Drugs Discovery Market Outlook:

Massive investments, a shift of market branded drugs to generic drugs and delayed processing of government regulations are hampering the market growth. The governments in North American countries such as the U.S. and Canada have also formulated encouraging policies for the investors to research and develop new drugs. The demand for drug discovery technologies in the region of North America gains high-income population, collectively promising healthy potential returns on

You can also purchase parts of this report. Do you want to check out a section wise price list

Drug Discovery Market - Porter's Five Force Analysis

Source: Envision Intelligence Analysis & Experts Insights.

*Graph shown for illustrative purpose only, the final report will have the graph with actual data and data labels

investments due to the high adoption rate of new technologies.

Global Drugs Discovery Market Trends:

Merck Receives an FDA Approval for ISENTRESS, in Combination with Other Antiretroviral Agents, for the Treatment of HIV-1 Infection in Newborns Weighing at Least 2 kg. Jubilant Biosys Ltd. announced that they successfully achieved an early stage milestone related to a collaborative program with Sanofi in Frankfurt, Germany focused on metabolic disorders.

Global Drugs Discovery Market Research report includes:

An executive summary condensing the whole report such that essential authority can rapidly twist up doubtlessly acquainted with brief overview and conclusion.
To have complete market analysis through industry value chain analysis, Porter’s five, PESTLE, SWOT analysis, and Y-o-Y analysis.
Regional and global diversity is analysed with the major countries and the unions. Scrutinizing the revenue generation on Year–On–Year
Identifying DROC in the current market and their impact in altering the market dynamics.
Competitive landscape analysis to identify the merger and acquisition which will have a comparative financial study with significant competitors.
Expertise investment opportunities by the analyst to the individual and organisation to have the better foothold in the market.
Identify the latest developments, market shares and strategies that are employed by the major market players, such as
Jubilant Biosys
Roche Holding AG
Sanofi
Infosys
Covance

Exclusive Benefits

Credibility and
Transparency

We actively recruit consumers, business professionals, and elusive individuals for our research panels, fostering enduring relationships. Our commitment to transparency is evident in the comprehensive listing of primary and secondary data sources, ensuring unwavering credibility in our reports.

Exhaustive
Coverage

Uncover the full spectrum with Envision Intelligence. Our detailed and extensive geographical coverage, coupled with survey consultation services, spans brand tracking, concept testing, and consumer behaviour analysis. Adapt to your evolving needs with scalable market research services that leave no facet unexplored.

Competitive
Edge

Stay ahead with Envision Intelligence. Our reports provide the latest market updates up to the date of purchase. Recognising the urgency of impactful decisions, we deliver timely analyses on the unprecedented choices made by CXOs during the COVID-19 crisis—providing valuable insights at no extra cost.

Golden
pportunities

Unearth hidden gems with Envision Intelligence. Our analysts and consultants conduct a comprehensive strategic sieve analysis, augmented by AI tools, to identify non-obvious, golden, and emerging opportunities. Evaluate possibilities that set you apart in the market.

Top-notch Reportsd
Guaranteed

Experience unparalleled depth with Envision Intelligence. Over 70% of our research is exclusive, establishing us as the premier source for in-depth and extensive market insights. Elevate your decision-making with reports that go beyond the ordinary.

Post Purchase
Support

Empower your journey with Envision Intelligence. Our commitment extends beyond the purchase. Enjoy post-purchase support for three months, with queries addressed within 24 business hours via telephone or email. We stand by you in your quest for ongoing success.